Home › Funds › PALISADE CAPITAL MANAGEMENT, LP › NVST
PALISADE CAPITAL MANAGEMENT, LP position in NVST
ENVISTA HOLDINGS CORPORATION · Health Care
PALISADE CAPITAL MANAGEMENT, LP reported holding 534,175 shares of NVST (ENVISTA HOLDINGS CORPORATION) in its Q2 2026 13F filing — a position valued at US$14.1M, representing 0.64% of its reported portfolio and ranking #48 among its reported holdings. PALISADE CAPITAL MANAGEMENT, LP has disclosed NVST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PALISADE CAPITAL MANAGEMENT, LP's NVST position evolved
PALISADE CAPITAL MANAGEMENT, LP first disclosed a stake in NVST in Q3 2023 at 451,191 shares (US$12.6M). The position peaked in Q1 2026 at 995,088 shares, worth US$25.2M. Across 12 filings, PALISADE CAPITAL MANAGEMENT, LP increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 534,175 shares valued at US$14.1M — a reduction of -460,913 shares quarter over quarter.. Notable position changes include a 61% increase in Q2 2024 (shares rose 19% over the following quarter), a 71% increase in Q3 2024 (shares fell 2% over the following quarter), a 46% trim in Q2 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 451.19K | $12.58M | New |
| Q4 2023 | 405.95K | $9.77M | Reduce |
| Q1 2024 | 414.60K | $8.86M | Add |
| Q2 2024 | 666.15K | $11.08M | Add |
| Q3 2024 | 1.14M | $22.45M | Add |
| Q4 2024 | 1.14M | $21.91M | Hold |
| Q1 2025 | 1.25M | $21.49M | Add |
| Q2 2025 | 1.21M | $23.66M | Reduce |
| Q3 2025 | 1.20M | $24.39M | Reduce |
| Q4 2025 | 1.07M | $23.24M | Reduce |
| Q1 2026 | 995.09K | $25.25M | Reduce |
| Q2 2026 | 534.17K | $14.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVST and 13F data
NVST (ENVISTA HOLDINGS CORPORATION) is a Health Care company. 38 other funds we track also report a position in NVST — the largest reported positions include ARIEL INVESTMENTS, LLC (US$258.7M), Gates Capital Management, Inc. (US$146.3M), Ilex Capital Partners (UK) LLP (US$115.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVST
- ARIEL INVESTMENTS, LLC 9.82M sh · $258.71M · Q2 2026
- Gates Capital Management, Inc. 5.55M sh · $146.31M · Q2 2026
- Ilex Capital Partners (UK) LLP 4.37M sh · $115.22M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.21M sh · $58.24M · Q2 2026
More on PALISADE CAPITAL MANAGEMENT, LP
FAQ
How long has PALISADE CAPITAL MANAGEMENT, LP held NVST?
PALISADE CAPITAL MANAGEMENT, LP has disclosed NVST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is PALISADE CAPITAL MANAGEMENT, LP's current position in NVST?
As of Q2 2026, PALISADE CAPITAL MANAGEMENT, LP holds 534.17K shares of NVST (ENVISTA HOLDINGS CORPORATION), valued at $14.08M, representing 0.64% of its reported portfolio and ranking #48.
Has PALISADE CAPITAL MANAGEMENT, LP been buying or selling NVST?
In the latest 13F filing (Q2 2026), PALISADE CAPITAL MANAGEMENT, LP reduced its position in NVST. The position peaked in Q1 2026 at 995.09K shares.
Which other funds hold NVST?
Other major institutional holders of NVST include ARIEL INVESTMENTS, LLC, Gates Capital Management, Inc., Ilex Capital Partners (UK) LLP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.